Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Market Growth 2025-2031

Publication ID:

LPI07254825

Publication Date:

July 24, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global Solid Phase Synthesis Carrier for Nucleic Acid Drugs market size is predicted to grow from US$ 67.5 million in 2025 to US$ 117 million in 2031; it is expected to grow at a CAGR of 9.7% from 2025 to 2031.
Solid Phase Synthesis Carrier for Nucleic Acid Drugs is a critical material used to support the solid-phase synthesis process of oligonucleotides and other nucleic acid-based drugs. These carriers are typically made from highly cross-linked polymers (such as polystyrene-divinylbenzene resins) or inorganic substrates (such as silica or glass beads), providing a stable chemical environment to ensure efficient nucleotide coupling during synthesis. This technology is essential in the development and manufacturing of nucleic acid drugs, including RNA interference (RNAi), antisense oligonucleotides (ASO), and messenger RNA (mRNA), directly impacting the purity, yield, and bioactivity of the final product. With the rapid expansion of the nucleic acid drug market, high-performance solid-phase synthesis carriers play a crucial role in improving production efficiency, reducing costs, and optimizing product quality.
United States market for Solid Phase Synthesis Carrier for Nucleic Acid Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Solid Phase Synthesis Carrier for Nucleic Acid Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Solid Phase Synthesis Carrier for Nucleic Acid Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Solid Phase Synthesis Carrier for Nucleic Acid Drugs players cover Nitto Denko, Sunresin, Cytiva, Tianjin Nankai Hecheng Science & Technology, Suzhou Nanomicro Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淪olid Phase Synthesis Carrier for Nucleic Acid Drugs Industry Forecast鈥� looks at past sales and reviews total world Solid Phase Synthesis Carrier for Nucleic Acid Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Solid Phase Synthesis Carrier for Nucleic Acid Drugs sales for 2025 through 2031. With Solid Phase Synthesis Carrier for Nucleic Acid Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Solid Phase Synthesis Carrier for Nucleic Acid Drugs industry.
This Insight Report provides a comprehensive analysis of the global Solid Phase Synthesis Carrier for Nucleic Acid Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Solid Phase Synthesis Carrier for Nucleic Acid Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Solid Phase Synthesis Carrier for Nucleic Acid Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Solid Phase Synthesis Carrier for Nucleic Acid Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Solid Phase Synthesis Carrier for Nucleic Acid Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Solid Phase Synthesis Carrier for Nucleic Acid Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
CPG
PS Beads
Segmentation by Application:
Pharmaceuticals
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Nitto Denko
Sunresin
Cytiva
Tianjin Nankai Hecheng Science & Technology
Suzhou Nanomicro Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Solid Phase Synthesis Carrier for Nucleic Acid Drugs market?
What factors are driving Solid Phase Synthesis Carrier for Nucleic Acid Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Solid Phase Synthesis Carrier for Nucleic Acid Drugs market opportunities vary by end market size?
How does Solid Phase Synthesis Carrier for Nucleic Acid Drugs break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Solid Phase Synthesis Carrier for Nucleic Acid Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Solid Phase Synthesis Carrier for Nucleic Acid Drugs by Country/Region, 2020, 2024 & 2031
2.2 Solid Phase Synthesis Carrier for Nucleic Acid Drugs Segment by Type
2.2.1 CPG
2.2.2 PS Beads
2.3 Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Type
2.3.1 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sale Price by Type (2020-2025)
2.4 Solid Phase Synthesis Carrier for Nucleic Acid Drugs Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Scientific Research
2.5 Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Application
2.5.1 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Breakdown Data by Company
3.1.1 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales Market Share by Company (2020-2025)
3.2 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Revenue by Company (2020-2025)
3.2.2 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sale Price by Company
3.4 Key Manufacturers Solid Phase Synthesis Carrier for Nucleic Acid Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Solid Phase Synthesis Carrier for Nucleic Acid Drugs Product Location Distribution
3.4.2 Players Solid Phase Synthesis Carrier for Nucleic Acid Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Solid Phase Synthesis Carrier for Nucleic Acid Drugs by Geographic Region
4.1 World Historic Solid Phase Synthesis Carrier for Nucleic Acid Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Solid Phase Synthesis Carrier for Nucleic Acid Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales Growth
4.4 APAC Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales Growth
4.5 Europe Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales Growth
4.6 Middle East & Africa Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales Growth
5 Americas
5.1 Americas Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Country
5.1.1 Americas Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Country (2020-2025)
5.1.2 Americas Solid Phase Synthesis Carrier for Nucleic Acid Drugs Revenue by Country (2020-2025)
5.2 Americas Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Type (2020-2025)
5.3 Americas Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Region
6.1.1 APAC Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Region (2020-2025)
6.1.2 APAC Solid Phase Synthesis Carrier for Nucleic Acid Drugs Revenue by Region (2020-2025)
6.2 APAC Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Type (2020-2025)
6.3 APAC Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Solid Phase Synthesis Carrier for Nucleic Acid Drugs by Country
7.1.1 Europe Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Country (2020-2025)
7.1.2 Europe Solid Phase Synthesis Carrier for Nucleic Acid Drugs Revenue by Country (2020-2025)
7.2 Europe Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Type (2020-2025)
7.3 Europe Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Solid Phase Synthesis Carrier for Nucleic Acid Drugs by Country
8.1.1 Middle East & Africa Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Solid Phase Synthesis Carrier for Nucleic Acid Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Solid Phase Synthesis Carrier for Nucleic Acid Drugs
10.3 Manufacturing Process Analysis of Solid Phase Synthesis Carrier for Nucleic Acid Drugs
10.4 Industry Chain Structure of Solid Phase Synthesis Carrier for Nucleic Acid Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Solid Phase Synthesis Carrier for Nucleic Acid Drugs Distributors
11.3 Solid Phase Synthesis Carrier for Nucleic Acid Drugs Customer
12 World Forecast Review for Solid Phase Synthesis Carrier for Nucleic Acid Drugs by Geographic Region
12.1 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Market Size Forecast by Region
12.1.1 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Forecast by Region (2026-2031)
12.1.2 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Forecast by Type (2026-2031)
12.7 Global Solid Phase Synthesis Carrier for Nucleic Acid Drugs Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Nitto Denko
13.1.1 Nitto Denko Company Information
13.1.2 Nitto Denko Solid Phase Synthesis Carrier for Nucleic Acid Drugs Product Portfolios and Specifications
13.1.3 Nitto Denko Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Nitto Denko Main Business Overview
13.1.5 Nitto Denko Latest Developments
13.2 Sunresin
13.2.1 Sunresin Company Information
13.2.2 Sunresin Solid Phase Synthesis Carrier for Nucleic Acid Drugs Product Portfolios and Specifications
13.2.3 Sunresin Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sunresin Main Business Overview
13.2.5 Sunresin Latest Developments
13.3 Cytiva
13.3.1 Cytiva Company Information
13.3.2 Cytiva Solid Phase Synthesis Carrier for Nucleic Acid Drugs Product Portfolios and Specifications
13.3.3 Cytiva Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cytiva Main Business Overview
13.3.5 Cytiva Latest Developments
13.4 Tianjin Nankai Hecheng Science & Technology
13.4.1 Tianjin Nankai Hecheng Science & Technology Company Information
13.4.2 Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Nucleic Acid Drugs Product Portfolios and Specifications
13.4.3 Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Tianjin Nankai Hecheng Science & Technology Main Business Overview
13.4.5 Tianjin Nankai Hecheng Science & Technology Latest Developments
13.5 Suzhou Nanomicro Technology
13.5.1 Suzhou Nanomicro Technology Company Information
13.5.2 Suzhou Nanomicro Technology Solid Phase Synthesis Carrier for Nucleic Acid Drugs Product Portfolios and Specifications
13.5.3 Suzhou Nanomicro Technology Solid Phase Synthesis Carrier for Nucleic Acid Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Suzhou Nanomicro Technology Main Business Overview
13.5.5 Suzhou Nanomicro Technology Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂